Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.

Sunwen ChouSophie AlainCarlos CerveraRoy F ChemalyCamille N KottonJens Dilling LundgrenGenovefa A PapanicolaouMarcus R PereiraJingyang J WuRose Ann MurrayNeil E BussMartha Fournier

Published in: The Journal of infectious diseases (2023)

NCT02931539 (SOLSTICE).

Keyphrases

clinical trial
phase ii
open label
double blind
study protocol
phase iii
randomized controlled trial